The go-no go test in attention deficit disorder is sensitive to methylphenidate

B. L. Trommer, J. A.B. Hoeppner, S. G. Zecker

Research output: Contribution to journalArticlepeer-review

80 Scopus citations


The go-no go test requires a subject to emit a simple motor response to one cue while inhibiting the response in the presence of another cue. This test has been effective in demonstrating impulsivity (elevated commission error rate) in children with attention deficit disorder (ADD). In this study, we examined the effects on go-no go test performance of two doses of methylphenidate (0.15 mg/kg and 0.3 mg/kg) administered in double-blind placebo-controlled fashion to children with ADD. Our results indicate that even modest doses of methylphenidate improve the go-no go performance of these children by decreasing their tendency to make impulsive commission errors. Thus the test is sensitive to the effects of methylphenidate and can be used to monitor a response to therapy.

Original languageEnglish (US)
Pages (from-to)S128-131
JournalJournal of child neurology
Issue numberSUPPL.
StatePublished - 1991

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology


Dive into the research topics of 'The go-no go test in attention deficit disorder is sensitive to methylphenidate'. Together they form a unique fingerprint.

Cite this